TD Asset Management’s Structure Therapeutics GPCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $906K | Hold |
43,686
| – | – | ﹤0.01% | 1074 |
|
|
2025
Q1 | $756K | Sell |
43,686
-45,196
| -51% | -$782K | ﹤0.01% | 1103 |
|
|
2024
Q4 | $2.41M | Sell |
88,882
-101,874
| -53% | -$2.76M | ﹤0.01% | 954 |
|
|
2024
Q3 | $7.96M | Sell |
190,756
-20,834
| -10% | -$870K | 0.01% | 689 |
|
|
2024
Q2 | $8.31M | Buy |
211,590
+68,490
| +48% | +$2.69M | 0.01% | 655 |
|
|
2024
Q1 | $6.13M | Sell |
143,100
-14,158
| -9% | -$607K | 0.01% | 727 |
|
|
2023
Q4 | $6.41M | Buy |
157,258
+5,082
| +3% | +$207K | 0.01% | 699 |
|
|
2023
Q3 | $7.67M | Buy |
152,176
+79,467
| +109% | +$4.01M | 0.01% | 634 |
|
|
2023
Q2 | $3.02M | Buy |
72,709
+36,763
| +102% | +$1.53M | ﹤0.01% | 852 |
|
|
2023
Q1 | $855K | Buy |
+35,946
| New | +$855K | ﹤0.01% | 1164 |
|